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ABSTRACT
The two endonucleases, Rad27 (yeast Fen1) and
Dna2, jointly participate in the processing of
Okazaki fragments in yeasts. Mus81–Mms4 is a
structure-specific endonuclease that can resolve
stalled replication forks as well as toxic recombin-
ation intermediates. In this study, we show that
Mus81–Mms4 can suppress dna2 mutational
defects by virtue of its functional and physical inter-
action with Rad27. Mus81–Mms4 stimulated Rad27
activity significantly, accounting for its ability to
restore the growth defects caused by the dna2
mutation. Interestingly, Rad27 stimulated the rate
of Mus81–Mms4 catalyzed cleavage of various sub-
strates, including regressed replication fork
substrates. The ability of Rad27 to stimulate
Mus81–Mms4 did not depend on the catalytic
activity of Rad27, but required the C-terminal 64
amino acid fragment of Rad27. This indicates that
the stimulation was mediated by a specific protein–
protein interaction between the two proteins. Our
in vitro data indicate that Mus81–Mms4 and Rad27
act together during DNA replication and resolve
various structures that can impede normal DNA rep-
lication. This conclusion was further strengthened
by the fact that rad27 mus81 or rad27 mms4
double mutants were synergistically lethal. We
discuss the significance of the interactions
between Rad27, Dna2 and Mus81–Mms4 in context
of DNA replication.
INTRODUCTION
During the replication of chromosomal DNA, replication
forks (RFs) are likely to encounter many potential obs-
tacles such as damaged lesions or tightly bound proteins,
resulting in the formation of stalled or collapsed RFs.
In order to maintain genome stability, cells have de-
veloped mechanisms to reestablish impaired RFs. One
mechanism contributing to RF restart is homologous re-
combination, which requires multiple enzymatic activities
(1,2). When progression of RFs is blocked, they regress
and form a Holliday junction (HJ)-like structure that
arises from the annealing of regressed leading and
lagging strands (1,3).
Collapsed or regressed RFs must be processed to restart
DNA replication, and can be restored with the aid of
RecQ-family helicases, which include Sgs1 (budding
yeast), Rqh1 (ﬁssion yeast), BLM, WRN and RTS
(humans) helicases (4). They promote reversion of re-
gressed RFs (4–6). The heterodimeric Mus81–Mms4
complex has been implicated in processing of stalled and
blocked RFs as well as in the processing of recombination
intermediates (2,7,8). Mus81–Mms4 is a structure-speciﬁc
endonuclease originally identiﬁed in a sgs1 synthetic-lethal
screen as a component that acts in parallel or redundant
pathways with Sgs1 (9–16). In vitro experiments showed
that the Mus81–Mms4 complex cleaved nicked Holliday
junctions, D loop, RFs, and 30 ﬂaps that could form in vivo
during the repair of damaged RFs (11,12,14–16). The
common structural feature of Mus81–Mms4 substrates is
the presence of three- or four-way junctions containing a
50 end at the junction, which serves to direct the cleavage
reaction by Mus81–Mms4 (9,11,12,17,18). Furthermore,
mus81 mutants exhibited hypersensitivity to methyl
methanesulfonate (MMS), cisplatin, hydroxyurea (HU)
and UV, all of which can lead to either the stalling or
the collapse of RFs (19–23). In general, inactivation of
genes involved in fork processing displayed several types
of genome instability, such as increased rates of both
mitotic and meiotic recombination, gross chromosomal
rearrangements and chromosome loss (4,5,24–27). Thus,
failure to repair impaired RFs puts cells at high risks of
genome instability, contributing in part to the develop-
ment of human diseases such as cancers (4). In humans,
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Flap endonuclease 1 (Fen1) is another structure-speciﬁc
endonuclease that resolves single-stranded ﬂap DNA
intermediates. With this activity, it participates in virtually
all DNA transactions such as DNA replication, repair and
recombination (28–30). In addition, many proteins
interact functionally and genetically with Fen1 (29).
During DNA replication, Fen1 is required to quantitative-
ly remove the RNA primer in Okazaki fragments (28–30).
RNase H, which can remove most of the initiator RNA
endonucleolytically, leaves one ribonucleotide residue
upstream of the RNA–DNA junction. The removal of
the last ribonucleotide requires Fen1 exonuclease activity
(28,30). Alternatively, Fen1 can cleave a 50 ﬂap containing
RNA–DNA generated by DNA polymerase (pol) d strand
displacement activity, to directly generate ligatable nicks.
In this case, the entire RNA primer can be removed in the
absence of RNase H activity (28,30). When a ﬂap is long
enough to be coated with replication protein A (RPA),
Dna2 endonuclease activity becomes essential because
the RPA-coated ﬂaps are resistant to Fen1 activity, but
stimulate Dna2-catalyzed cleavage. Such processing
events generate short ﬂaps devoid of RPA, which can be
processed rapidly by Fen1 (31). Thus, RPA provides a
mechanism by which the processing of ﬂaps can switch
from Dna2 to Fen1 (31). The concerted action of Dna2
and Fen1 efﬁciently generates nicks that can be sealed by
DNA ligase 1 (31).
It is worthwhile to mention that MUS81 or MMS4
interacted genetically with several genes involved in
DNA replication. For example, deletion of RNH202
(a subunit of RNase H2) in a mus81 background increased
its sensitivity to camptothecin and to HU, while these
drugs had no signiﬁcant effect on rnh202 alone (32).
This result suggests that RNase H2 and Mus81–Mms4
act in parallel to overcome camptothecin- and
HU-induced DNA damage. Furthermore, rad27cells
lacking yeast Fen1 (yFen1) suffer severe synthetic
growth defects or lethality in combination with mutations
in mus81 or mms4 (33). Both RNase H2 and Fen1 are
known to play critical roles in processing of Okazaki
fragments in eukaryotes. However, the manner in
which Mus81–Mms4 participates in Okazaki fragment
processing is presently unclear. In this report, we have
investigated functional and physical interactions between
Dna2, Fen1 and Mus81–Mms4. Our ﬁndings indicate that
Mus81–Mms4 and Rad27 act together via direct inter-
actions during processing of Okazaki fragments and reso-
lution of damaged RFs.
MATERIALS AND METHODS
Enzymes, antibodies, DNA and nucleotides
Oligonucleotides used in this study were commercially
synthesized by Genotech (Daejeon, Korea) and their se-
quences are listed in Table 1. All oligonucleotides were
gel-puriﬁed prior to use. Nucleoside triphosphates were
obtained from Sigma-Aldrich, and [g-
32P] adenosine tri-
phosphates (ATP) (>5000Ci/mmol) was purchased from
IZOTOP (Budapest, Hungary). Restriction endonucleases
and polymerase chain reaction (PCR) polymerases were
purchased from either New England Biolabs (Beverly,
MA) or Enzynomics (Daejeon, Korea). The pRS
plasmids were purchased from New England Biolabs.
The pET28 vectors used for protein expression in
Escherichia coli were from Novagen (Darmstadt,
Germany). Isopropyl b-D-1-thiogalactopyranoside
(IPTG) and X-gal were from ElpisBiotech (Daejeon,
Korea). Imidazole was from Acros Organics (Geel,
Belgium). The uracil analog, 5-ﬂuoroorotic acid (5-FOA)
was obtained from Duchefa Biochemie (Haarlem,
Netherland). Antibodies used for immunoprecipitation
or western blotting were obtained from; anti-His
(Qiagen, Valencia, CA, USA), PAP (an antibody:peroxid-
ase conjugate, Sigma-Aldrich), and anti-FLAG
(Sigma-Aldrich).
Preparation of substrates
The DNA substrates used in this study included 30 ﬂap
(30F), RF, RF leading strand regressed (RLe), nicked
Holliday junction (nHJ) and 50 double ﬂap (50DF).
DNA substrates for nucleases were prepared using the
synthetic oligonucleotides listed in Table 1. The oligo-
nucleotides used to construct DNA substrates are
indicated in each ﬁgure with encircled numbers at their
schematic structure. Brieﬂy, one of the three or four
strands (10pmol) was ﬁrst 50-end labeled with [g-
32P]
Table 1. Oligonucleotides used to construct DNA substrates in this study
No. Nucleotide sequences (length in nt)
15 0-GAAAACATTATTAATGGCGTCGAGCGTCCGTAGGCACAAGGCGAACTGCTAACGG-30 (55)
25 0-CCGTTAGCAGTTCGCCTTGTGCCTATTTTTTTTTTTTTTTTTTTT-30 (45)
35 0-CGGACGCTCGACGCCATTAATAATGTTTTC-30 (30)
45 0-CGAACAATTCAGCGGCTTTAACCGGACGCTCGACGCCATTAATAATGTTTTC-30 (52)
55 0-GAAAACATTATTAATGGCGTCGAGCTAGGCACAAGGCGAACTGCTAACGG-30 (50)
65 0-CGCATCCTATCAGTTCGTATGCAGTGTCCGGTTAAAGCCGCTGAATTGTTCG-30 (52)
75 0-ACTGCATACGAACTGATAGGATGCG-30 (25)
85 0-GAAAACATTATTAATGGCGTCGAGC-30 (27)
95 0-CCGTTAGCAGTTCGCCTTGTGCCTA-30 (25)
10 50-CCGTTAGCAGTTCGCCTTGTGCCTAG-30 (26)
11 50-GCTTTAACCGGACGCTCGACGCCATTAATAATGTC-30 (38)
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manufacturer’s protocol. The labeled oligonucleotides
were then annealed to other oligonucleotides (20pmol)
in buffer (5mM HEPES-NaOH/pH7.5, 300mM NaCl)
using a PCR machine (95 C for 5min, 65 C for 30min
and  0.5 C/min to 25 C). All annealed substrates were
puriﬁed by 10% polyacrylamide gel electrophoresis
(PAGE) prior to use.
Multi-copy suppression of dna2K1080E lethality
The plasmid pRS325-MUS81/MMS4 was transformed
into yJA1B+JK65 (MAT  ade2-101 ura3-52 lys2-801
trpD63 his3-D200 leu2-D1 GAL
+ dna2D::HIS3) harboring
both pRS316-DNA2 and pRS314-dna2K1080E.I n
pRS325-MUS81/MMS4, expression of Mus81 and
Mms4 proteins were driven by their native promoters.
The transformants were grown on SD-His-Trp-Leu
plates. Single colonies from transformants were grown in
liquid media, and the cells were spotted in 10-fold serial
dilutions onto SD-His-Trp-Leu plates with or without
5-ﬂuoroorotic acid (5-FOA). The plates were incubated
for 3 days at 30 C. Loss of pRS316-DNA2 in the
presence of 5-FOA in the media allowed us to measure
whether the expression of Mus81–Mms4 (in pRS325) sup-
pressed the dna2K1080E mutant allele (in pRS314).
Construction of expression vectors
All recombinant proteins were expressed as native or
fusion proteins in E. coli by the use of the pET21c and
pET28a (Novagen). Constructions of all expression
vectors were performed similarly as follows: PCR frag-
ments were obtained with appropriate pairs of primers,
and ampliﬁed fragments were puriﬁed using QIA-quick
gel extraction kit (Qiagen). All fragments ampliﬁed con-
tained a unique restriction site at each end to allow direc-
tional cloning into a relevant vector. The authenticity of
all constructed plasmids was conﬁrmed by sequencing
inserted DNA fragments. In order to produce
hexahistidine-tagged Mms4 at its N-terminus, for
example, a pair of primers, 50-GAA TTC ATG AGC
CG ATC GTT GAT-30 and 50-ACG CGT CGA CTC
ATT CAA TAG TAT CAT T-30 (EcoRI and SalI sites
used for cloning are underlined, respectively) were used
to amplify the MMS4 gene with yeast genomic DNA as
template. The ampliﬁed fragments were digested with
EcoRI and SalI, and cloned into pET28a cleaved with
EcoRI and SalI, generating pET-His6-Mms4. The
pET-Mus81 was prepared by the use of 50-GGA ATT
CCA TAT GGA ACT CTC ATC AAA C-30 and 50-
GCG GCC GCC TA AGT TTA CCA AAA GC (NdeI
and NotI site, respectively). The ampliﬁed fragments were
then cloned into NdeI and NotI sites of pET21c, to
generate pET-Mus81. To express the Mus81–Mms4
complex, the MUS81 gene was ampliﬁed from the
pET-Mus81 construct above with primers 50-ACA GCA
TGC AGA TCT CGA TCC CGC GAA-30 and 50-TCA
GCA TGC AAA AAA CCC CT-30 (SphI). The ampliﬁed
fragments were cloned into a SphI site of pET28- His6-
Mms4, producing pET28–His6–Mms4–Mus81.
To express Rad27 (yeast Fen1) as a fusion protein
(Rad27-FLAG) with a FLAG tag at its C-terminus, the
RAD27 gene was PCR-ampliﬁed using yeast genomic
DNA as template with the primers; 50-GGA ATT CAA
ACA AAA AGA ACA GGG A-30 and 50-CCG CTC
GAG TCA CTT ATC GTC ATC GTC CTT GTA
GTC TCT TCT TCC CTT TGT GAC-30 (EcoRI and
XhoI). The ampliﬁed fragment was cloned into EcoRI
and XhoI sites of pRS426, generating pRS426-Rad27-
FLAG. The cloned fragment contained the native Rad27
promoter. To express Rad27 with a C-terminal tagged
hexahistidine (Rad27-His6), the RAD27 gene was
ampliﬁed with the primers; 50-GGA ATT CAT GGG
TAT TAA AGG TTT G-30 and 50-CCG CTC GAG
TCT TCT TCC CTT TGT GAC-30 (EcoRI and XhoI).
The ampliﬁed PCR fragments were digested with EcoRI
and XhoI, and cloned into pET21a cleaved with EcoRI
and XhoI, resulting in pET21a-Rad27-His6. All truncated
forms of Rad27 were cloned into plasmid pGEX4T-1, and
produced as a fusion protein with GST fused to its
N-terminus. They included Rad271–366, Rad27261–382,
Rad27261–317, Rad27318–382, Rad27318–350, Rad27351–382
and Rad27335–366 (the subscript indicates positions of
amino acids).
Puriﬁcation of Mus81–Mms4 complex and Rad27
Escherichia coli BL21-RIL cells (Stratagene) containing
pET28–His6–Mus81–Mms4 were grown at 37 C until
A600=0.5, and expression was induced with 0.5mM
IPTG. The cells (4l) were grown for an additional 2h at
25 C and collected by centrifugation. Cells (7.5g, wet
weight) were resuspended in 100-ml buffer A150 (25mM
HEPES-NaOH/pH 7.5, 10% glycerol, 0.01% NP-40,
1mM EDTA, 1mM dithiothreitol, 150mM NaCl and
0.1mM phenylmethylsulfonate). The subscript in buffer
A150 indicates concentration of NaCl in millimoles. Cells
were sonicated ﬁve times for 1min with a 5-min cooling
interval, and the lysates were centrifuged at 100000g for
30min. The resulting extract (4mg/ml, 100ml) was loaded
onto a phosphocellulose column (5ml,  1.5 5cm)
equilibrated with buffer A150. The column was washed
with 25-ml buffer A150, and proteins eluted with a linear
NaCl gradient (50ml) from 0.15 to 1M in buffer A
without DTT and EDTA. Mus81–Mms4 eluted at
 650mM NaCl, and peak protein fractions were
pooled. The pooled proteins (1.4mg/ml, 15ml) were
incubated with Ni
2+–NTA beads (1ml, Qiagen) in the
presence of 10mM imidazole for 2h; the mixture was
then poured into a column ( 0.7 5cm), and then
washed with 10-ml buffer A500 plus 10mM imidazole,
followed by washing with 10-ml buffer A500 plus 50mM
imidazole. The Mus81–Mms4 complex was eluted with
buffer A500 plus 200mM imidazole. Eluted peak fractions
(0.38mg/ml, 1.5ml) were pooled, and a portion (0.25ml)
was subjected to glycerol gradient centrifugation (5ml,
15–35% glycerol in 25mM HEPES-NaOH/pH 7.5,
500mM NaCl, 0.01% NP40) at 45000r.p.m. for 24h in
a Beckman SW55Ti rotor.
For puriﬁcation of the Rad27-His6 protein, E. coli
BL21-RIL cells (2l) harboring pET21-Rad27-His6 were
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ition of 0.5mM IPTG to induce protein expression.
The cells were incubated for an additional 4h at 25 C,
and then harvested. The resulting cell pellet (4.5g,
wet weight) was resuspended in 65-ml buffer A100
without DTT and EDTA. Crude extracts were
prepared as described above for Mus81–Mms4. The
extract (3.2mg/ml, 65ml) was loaded onto a 1.5-ml
Ni
2+–NTA ( 1   5cm) column, followed by successive
washings with 10-ml buffer A100 and 10-ml buffer A100
plus 50mM imidazole without DTT and EDTA. Bound
proteins were eluted with buffer A100 plus 200mM imid-
azole. The peak protein fractions (0.42mg/ml, 15ml) were
pooled and loaded onto a Heparin column (1ml,
 0.7 5cm) equilibrated with buffer A100. The column
was then washed with 10-ml buffer A200, and bound
proteins eluted with buffer A plus 500mM NaCl. Half
(0.25ml) of the pooled fraction (1.23mg/ml, 0.5ml) was
subjected to glycerol gradient sedimentation as described
for the isolation of Mus81–Mms4. Glycerol gradient frac-
tions obtained from the Mus81–Mms4 and Rad27 prep-
arations were analyzed in sodium dodecyl sulfate
(SDS)-PAGE, followed by Coomassie blue staining. The
protein yield was quantiﬁed using bovine serum albumin
(BSA) as standard (Bio-Rad).
Derivatives of GST-Rad27 fusion proteins were puriﬁed
using GST-beads (Amersham Biosciences) as recom-
mended by the manufacturer.
Nuclease assays
Standard Mus81–Mms4 nuclease assays were performed
in reaction mixtures (10ml) containing 25mM Tris–HCl/
pH 8.0, 100mM NaCl, 10mM MgCl2, 0.2mM DTT,
0.1mg/ml BSA, 0.1% NP-40, 5% glycerol, 10fmol of
DNA substrates and enzyme as indicated. Reaction
mixtures were incubated at 30 C for 30min, and then
deproteinized with 0.2% SDS (ﬁnal concentration) and
10mg proteinase K, followed by incubation for 10min at
37 C. After adding 2ml of 6X stop buffer (60mM EDTA/
pH 8.0, 40% sucrose, 0.6% SDS, 0.25% bromophenol
blue and 0.25% xylene cyanol), mixtures were
electrophoresed at 150V through a 12% PAGE in 0.5 
TBE (45mM Tris, 45mM boric acid and 1mM EDTA).
Gels were dried on a DEAE-cellulose paper (Whatman)
and autoradiographed. Labeled DNA products were
quantiﬁed by a Phosphorimager (Molecular Dynamics,
Inc.). Rad27 nuclease assays were carried out as previous-
ly described [Kim et. al. (39)], except that the amount of
DNA substrate used was 10fmol. When required, Mus81–
Mms4 proteins were diluted in buffer (25mM
HEPES-NaOH at pH 7.5, 500mM NaCl, 0.25mg/ml
BSA, 0.01% NP40 and 20% glycerol), while Rad27
proteins were diluted in the same buffer but with
150mM NaCl.
Determination of kinetics parameters
Kinetic analyses were repeated in triplicate using
increasing amounts (5, 10, 25, 50, 100, 200 and 500fmol)
of a double-ﬂap substrate prepared with oligonucleotides
5, 10 and 11 (template, upstream primer and labeled
downstream primer, respectively; see Table 1 for the se-
quences and sizes). Reactions were carried out with 1fmol
of Rad27 and 30fmol of Mus81–Mms4 containing 90mM
NaCl per reaction. These reaction conditions led to
reliable levels of products at early time points. Reaction
mixtures (20ml) were assembled on ice, followed by
preincubation on ice for 10min. Reactions were initiated
by incubation at 37 C. Aliquots were withdrawn at 8min
and then added to 4ml of 6X stop buffer. The amount of
products formed was analyzed as described above. Kinetic
parameters were obtained based on the Michaelis–Menten
equation. V=d[P]/dt, where [P] is the amount of products
in nanomoles. The concentration of [P] was calculated
using the equation, [P]=Icleaved/(Iuncleaved + Icleaved)  
[S], where [S] is concentration of substrate used, and
Icleaved and Iuncleaved are band intensities of products
formed and substrates left, respectively. The initial
velocity was plotted against [S], and the values Km and
Vmax were calculated by nonlinear regression using
Sigma Plot (Systat Software Inc.) to avoid distortion of
the experimental errors, which can occur during reciprocal
transformation of the data.
Immunoprecipitation
In order to detect in vivo interactions between Mus81–
Mms4 and Rad27, a BJ2168-Mus81-TAP strain was con-
structed by inserting the Mus81-TAP into its native
genomic locus in BJ2168 cells (MATa ura3-52 trp1-D63
leu2D prb1-1122 pep4-3 prc1-407 GAL2). These cells
were grown to A600=2.0–3.0 in an appropriate selective
media. BJ2168-Mus81-TAP/Rad27-FLAG strains were
constructed by replacing chromosomal RAD27 with
Rad27-FLAG. Cell lysates from BJ2168-Mus81-TAP/
Rad27-FLAG were prepared by disrupting cells using a
bead beater (Biospec product) in IP buffer (25mM
HEPES-NaOH/pH 7.5, 150mM NaCl, 10% glycerol,
0.05% NP-40, and 1mM PMSF). Clariﬁed lysates were
incubated with 200ml (50% slurry) of FLAG-agarose
(Sigma) at 4 C for 2h with rocking. After a brief centri-
fugation, the beads were washed ﬁve times with IP buffer
prior to western blot analyses with PAP or FLAG
antibodies.
In vitro interactions between Mus81–Mms4 and Rad27
were carried out as follows; recombinant proteins (5pmol
of each) were mixed in IP buffer (0.1ml), and the mixture
was incubated on ice for 1h. Polyclonal Rad27 antibodies
and protein-A agarose beads (5ml each) were added and
the mixture was incubated at 4 C for 2h with rocking.
After incubation, beads were collected by centrifugation,
and washed eight times with IP buffer (0.5ml for each
wash), followed by western blot analyses with anti-His
antibodies.
GST-pull-down assay
For the puriﬁcation of GST-Rad27 and its derivatives,
E. coli BL21-RIL cells harboring plasmids
(pGEX4T-1-Rad27X–Y, where X and Y indicate the
amino acids present in the Rad27 truncated fragment)
were grown at 37 Ct oa nA 600 of 0.5: Protein expression
was induced with 1mM IPTG for 4h at 25 C. Cells were
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HEPES-NaOH/pH 7.5, 10% glycerol, 0.01% NP-40,
150mM NaCl and 0.1mM PMSF). Lysates were then
mixed with 0.1ml glutathione-agarose beads (Amersham
Biosciences) and the mixtures incubated at 4 C for 1h.
The GST-agarose beads were collected by centrifugation,
and washed once with lysis buffer (1ml) plus 1M NaCl
and once with lysis buffer (1ml). The amount of
GST-Rad27 bound to beads was quantiﬁed using BSA
as standard (Bio-Rad) in a Coomassie-stained 10%
SDS-polyacrylamide gel. Beads containing 100pmol of
GST-Rad27 were mixed with 1pmol of Mus81–Mms4
in binding buffer (25mM HEPES-NaOH/pH 7.5, 10%
glycerol, 0.01% NP-40, 150mM NaCl), and then
incubated at 4 C for 1h. Beads were then collected by
centrifugation, washed eight times with IP buffer (0.5ml
each time), and then subjected to 10% SDS–PAGE for
immunoblotting with anti-His monoclonal antibodies.
When necessary, GST-Rad27 was eluted from the GST
beads with 20mM glutathione to the beads.
RESULTS
Multi-copy expression of MUS81–MMS4 suppresses
lethality of dna2 helicase mutant
Previously, we showed that overexpression of Mph1
rescued the lethality of dna2K1080E (34), a mutant allele
that abolished the helicase activity of Dna2 (35). We noted
that the helicase domains of Mph1 and FancM shared
some homology at their N-terminal region (36). In
addition, the C-terminal region of FancM contained
amino acid sequences that are conserved in ERCC4 and
Mus81 family of endonucleases (17). This raised the pos-
sibility that Mph1 and Mus81 may function together to
play a role similar to that of FancM. This possibility was
supported by our ﬁnding that the protein–protein inter-
action was detected between Mph1 and Mus81 with yeast
two hybrid assays (data not shown). We then assumed
that Mus81 was very likely to interact functionally with
Dna2 like Mph1. To test this possibility, we examined the
ability of Mus81–Mms4 to suppress the lethality of
dna2K1080E mutant in a manner similar to that
observed with Mph1. For this purpose, we constructed
multi-copy plasmids expressing Mus81 and Mms4, indi-
vidually and in combination, under the control of their
native promoters. As shown in Figure 1, transformants
expressing one of the two proteins or both signiﬁcantly
suppressed the lethality of dna2K1080E. Expression of
either Mus81 (MUS81) or Mms4 (MMS4) alone also
resulted in signiﬁcant suppression of dna2K1080E. The
extent of suppression by the Mus81–Mms4 complex
(MUS81–MMS4) was nearly as efﬁcient as that observed
with overexpression of the large subunit of RPA (RFA1,
positive control; ref. 31), whereas an empty vector control
(none) failed to do so.
Puriﬁcation of recombinant Mus81–Mms4 complex
and Rad27
To gain insight into the mechanism by which Mus81–
Mms4 suppressed the dna2 helicase mutation, we
puriﬁed the Mus81–Mms4 complex as described in
‘Materials and Methods’ section and investigated
whether it could affect the endonuclease activities of
either Dna2 or Fen1. The Mus81–Mms4 complex and
two forms of Rad27 (Rad27-His6, Rad27 with a
hexahistidine tag at its C-terminus; GST-Rad27, Rad27
with a GST tag at its N-terminus) were puriﬁed to near
homogeneity (>95%, Figure 1B). They were devoid of
nonspeciﬁc nuclease activities that interfered with our
nuclease assays (see below). GST-Rad27 had virtually no
endonuclease activity, whereas Rad27-His6 possessed
wild-type-like activity (data not shown). This is consistent
with the observation that the N-terminal regions of Fen1
were critical to the formation of its catalytic site (37).
The puriﬁed recombinant Mus81–Mms4 complex was
active and cleaved a variety of substrates, including
those containing a 30F, RF, RLe and nHJ structures
(Figure 1C). We noted that Mus81–Mms4 displayed a
marked sigmoidal response to the level of enzyme added.
Cleavage products were hardly observed with <5fmol of
Mus81–Mms4, whereas saturation levels of cleavage
products were formed with 10fmol or more of the
enzyme produced (Figure 1D). The cleavage products
migrated similarly in the polyacrylamide gel used in this
study. The cleavage of the labeled strands in these sub-
strates produced largely 20-nt (with the 30F substrate) or
22-nt long ssDNA products (with all the other substrates),
indicating that the cleavage had occurred 5nt away from
nicks present in each substrate (data not shown). We also
tested other substrates including a 50F. Y-structure, intact
Holliday junction and RF (RLa), and found that the
Mus81–Mms4 complex poorly or hardly cleaved these
substrates; the RLa substrate was weakly (100-fold less
than the RLe substrate) cleaved (data not shown), while
others were hardly cleaved. These ﬁndings are in keeping
with the substrate speciﬁcity determined in the previous
reports (14,38).
Mus81–Mms4 stimulates endonuclease activity of Rad27
Since other multi-copy suppressors of dna2 mutants like
Mgs1, Mph1 or Vts1 markedly stimulated the endonucle-
ase activity of either Dna2 or Rad27 or both (34, 39,40),
we decided to examine whether Mus81–Mms4 was able to
stimulate the nuclease activities of Rad27 and Dna2. For
this purpose, we ﬁrst tested the ability of Mus81–Mms4 to
stimulate Fen1 activity using 50DF substrate with a 50 13-
and 30 1-nucleotide ﬂap, a physiological substrate for Fen1
(41). When reaction mixtures containing ﬁxed levels (0.2
and 1fmol) of Rad27 were supplemented with increasing
amounts (15, 30, 60 or 120fmol) of Mus81–Mms4, there
was a marked stimulation of Rad27-catalyzed cleavage of
the 50DF substrate (Figure 2A). With 0.2fmol of Rad27
alone, virtually no cleavage products were formed
(Figure 2A, lane 3). However, the addition of Mus81–
Mms4 markedly stimulated Rad27 activity (Figure 2A,
compare lanes 3 and 4–7). We observed an  12-fold
stimulation by Mus81–Mms4 at higher levels of Rad27
(1fmol) (Figure 2A, lanes 8–12). In the absence of
Rad27, no cleavage products were detected even with
the highest level (120fmol) of Mus81–Mms4 (Figure 2A,
Nucleic Acids Research, 2010,Vol.38, No. 21 7615lane 13), in keeping with the stringent substrate speciﬁcity
of Mus81–Mms4. We also analyzed the products formed
in a high-resolution gel, and noted no changes in the
cleavage site of Fen1 (data not shown). We found that
Mus81–Mms4 also stimulated the 50 to 30 exonuclease
activity of Rad27 when a nicked duplex substrate was
used (data not shown). In conclusion, these ﬁndings
indicate that Mus81–Mms4 is able to stimulate the
activity of Rad27 without altering its speciﬁcity.
Subsequently, we performed a time-course experiment
with a ﬁxed amount of Rad27 in the absence and presence
of Mus81–Mms4. The rate of products formed by Rad27
(1fmol) in the presence of Mus81–Mms4 (30fmol) was 10-
to 20-fold greater than that measured in its absence
(Figure 2B and C). Mus81–Mms4 alone was totally
inactive (Figure 2B, lane 3). Considering that elevated
levels of Fen1 resulted in suppression of dna2 mutations
(42), our ﬁndings that the Mus81–Mms4 complex
stimulated the activity of Rad27 could explain why
Mus81–Mms4 suppressed a dna2 mutation when ex-
pressed in a multi-copy plasmid (see below for further
discussion). We also discovered that Mus81–Mms4
stimulated the endonuclease activity of Dna2, but
weakly (2- to 3-fold at most) (data not shown). Thus, we
could not rule out the possibility that the weak stimulation
of Dna2 by Mus81–Mms4 could partially contribute to
the suppression of the dna2 mutation.
Effect of Mus81–Mms4 on the kinetic parameters of the
Rad27 cleavage
We next determined the reaction kinetic parameters, Km
and Vmax, as described in ‘Materials and Methods’
section. The addition of Mus81–Mms4 resulted in a sig-
niﬁcant increase ( 2.5-fold) in Vmax (and thus kcat), and a
reduction ( 4-fold) of Km (Table 2). Thus, the catalytic
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Figure 1. (A) suppression of dna2K1080E by multi-copy expression of Mus81–Mms4. The dna2D strain harboring pRS316-DNA2 and pRS314-
dna2K1080E was transformed with pRS325-MUS81/MMS4 (MUS81–MMS4), pRS325 (Vector, vector only control), or pRS325-RFA1 (RFA1,
positive control). Transformants were grown on SD-Leu-Trp-His plates. Drop-dilution assays were carried out in 10-fold serial dilutions (10
4,
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3,1 0
2 and 10
1 cells) and spotted on SD-Leu-Trp-His plates in the absence (–5-FOA) or presence (+5-FOA) of 5-ﬂuoroorotic acid. Cells were
grown at 30 C for 3 days. (B) Puriﬁcation of recombinant Mus81–Mms4 and Rad27 proteins. SDS–PAGE analysis of puriﬁed Mus81–Mms4,
Rad27-His6 and GST-Rad27 proteins. Mus81–Mms4 (1.6mg, lane 2), Rad27-His6 (1.4mg, lane 3) and GST-Rad27 (1.4mg, lane 4) were subjected to a
10% SDS–PAGE analysis, followed by Coomassie blue staining. Mw, molecular weight marker. (C) Cleavage of four different DNA substrates by
puriﬁed Mus81–Mms4. Reactions were carried out in standard reaction mixtures containing 10fmol of each substrate as described in ‘Materials and
Methods’ section. The substrates tested included 30F, 30 ﬂap; RF, replication fork; RLe, regressed leading-strand replication fork; nHJ, nicked
Holliday junction. The structure of each substrate is schematically illustrated at the top of the autoradiograph, and oligonucleotides used to construct
the DNA substrates are indicated by encircled numbers (Table 1). Increasing amounts (5, 10 and 20fmol) of Mus81–Mms4 were added to reaction
mixtures that were incubated for 30min at 30 C. Reactions were terminated with 0.2% SDS, 10mg proteinase K, followed by incubation for 15min
at 37 C. The products were subjected to a 12% PAGE in 0.5  TBE at 150V. The arrows on each substrate indicate the sites of cleavage. Asterisk
indicates the position of
32P-labels at 50 DNA ends. Open triangle indicates boiled substrate control. Minus sign indicates no enzyme control. (D) The
amount (fmol) of cleavage product formed in (C) was plotted against the amounts of Mus81–Mms4 used.
7616 Nucleic Acids Research, 2010,Vol.38, No. 21efﬁciency (kcat/Km) of Rad27 increased markedly
( 11-fold) in the presence of Mus81–Mms4 (Table 2).
The increase in Vmax suggests that the protein–protein
interaction between Mus81–Mms4 and Rad27 may
induce conformational change in Rad27, which in turn
leads to an increased rate of catalysis. The decrease in
Km may reﬂect the fact that Mus81–Mms4 stabilizes the
binding of Rad27 to the substrate and contributes to its
increased afﬁnity for DNA substrates. The two kinetic
parameters determined suggest that the mechanism by
which Mus81–Mms4 stimulates Rad27 activity could be
similar to the mechanism by which PCNA stimulates the
activity of Rad27. It was shown that PCNA increased
Vmax 2-fold, but decreased Km  12 fold of Rad27 (43).
It has been postulated that the direct physical interaction
of PCNA with Fen1 leads to the tethering of Fen1 at
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Figure 2. The Mus81–Mms4 complex stimulates the endonuclease activity of Rad27. (A) Standard reactions for Rad27 were carried out with two
different levels (0.2 or 1fmol) of Rad27 in the presence of increasing amounts (15, 30, 60 and 120fmol) of Mus81–Mms4. Reaction mixtures
contained 25mM Tris–HCl/pH 8.0, 2mM MgCl2, 2mM DTT, 0.25mg/ml BSA and 10fmol of the 50DF substrate. The schematic structure of the
substrate is as shown, and oligonucleotides used to construct the substrate are indicated by encircled numbers (Table 1). The reaction mixtures, after
addition of indicating enzyme levels, were incubated for 15min at 37 C. Reactions were terminated with 0.2% SDS, 10mg proteinase K, followed by
an additional incubation for 15min at 37 C. The reaction products were analyzed similarly as described in Figure 1C. The arrows on the substrates
indicate sites of cleavage. Asterisk indicates the position of
32P-labels at 50 DNA ends. Open triangle indicates boiled substrate control. S, substrate
only control. (B) A time-course experiment of Rad27 endonuclease activity in the absence (–) or presence (+, 30fmol) of Mus81–Mms4. The reaction
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Table 2. Kinetic parameters for Rad27 endonuclease activity in the presence of Mus81–Mms4
Vmax (nM/s 10
-3) Km (nM) kcat (s
 1 10
 2) kcat/Km (s
 1M
 1 10
7)
Rad27 alone 3.64±0.75 25.33±5.51 7.28±1.49 0.30±0.08
Rad27+Mus81/Mms4 9.58±2.96 5.96±3.10 19.17±5.91 3.47±0.82
Nucleic Acids Research, 2010,Vol.38, No. 21 7617DNA cleavage site and contributes to the increased
afﬁnity of Fen1 for DNA substrates.
Rad27 stimulates Mus81–Mms4 cleavage activity
Since genetic analyses revealed that rad27 was synthetic-
ally lethal with either mus81 or mms4 (33), we tested the
alternative possibility that Rad27 might affect the Mus81–
Mms4 endonuclease activity. To conﬁrm this possibility,
we incubated the 30F substrate with two different levels
(2.5 and 5fmol) of Mus81–Mms4 in the presence of
increasing amounts (0–200fmol) of Rad27 (Figure 3A).
As expected from substrate speciﬁcity, the 30F substrate
was not cleaved by Rad27 (200fmol; Figure 3A, lanes 11
and 20). In addition, the levels (2.5 and 5fmol) of Mus81–
Mms4 alone hardly produced cleavage products
(Figure 3A, lanes 3 and 12) in keeping with the results
as shown in Figure 1D. In the presence of Rad27,
however, the 30F substrate was efﬁciently cleaved by
Mus81–Mms4 (Figure 3A and B). In the presence of 2.5
and 5fmol of Mus81–Mms4, more than 20fmol of Rad27
was required for detectable levels of cleavage products
(Figure 3A, lanes 8 and 16). The cleavage reaction plat-
eaued in the presence of more than 100fmol of Rad27
(Figure 3A and B). We also examined the Rad27 stimula-
tion of the Mus81–Mms4 cleavage activity using three
other substrates, RF, RLe and nHJ. Like the 30F sub-
strate, cleavage of these substrates by Mus81–Mms4
increased in a Rad27-dependent manner (data not
shown). Our data suggest that Rad27 stimulated
Mus81–Mms4 regardless of substrates used. In addition,
Rad27 did not alter the sites cleaved by Mus81–Mms4.
The high-resolution gel analyses showed that identical
products were formed in reactions containing Mus81–
Mms4 and those also containing Rad27 (data not shown).
Rad27 stimulates Mus81–Mms4 in a single catalytic cycle
In order to investigate whether Rad27 stimulates Mus81–
Mms4 at physiological salt concentrations, we decided to
determine concentrations of NaCl for optimal cleavage of
the 30F substrate by Mus81–Mms4. Prior to this, we
examined the effect of Mg
2+ on the Fen1-mediated stimu-
lation of Mus81–Mms4. In the absence of Mg
2+, cleavage
did not occur (Figure 4A, lanes 2–4). We noted that in-
creases in Mg
2+ concentrations (2.5–10mM) caused
gradual decrease in cleavage efﬁciencies of 30F DNA by
Mus81–Mms4 alone (Figure 4A, compare lanes 5, 8, 11
and 14). In contrast, the addition of Rad27 (25 or
100fmol) allowed Mus81–Mms4 to overcome the inhibi-
tory effect of increasing concentrations of Mg
2+, resulting
in a marked increase in the cleavage of 30F substrate by
Mus81–Mms4. Higher concentrations of MgCl2 caused
more robust stimulation of Mus81–Mms4 by Fen1; at
2.5mM MgCl2, stimulation was weak (<2-fold) with
Rad27 added (Figure 4A, lanes 5–7). At 7.5 or 10mM
MgCl2, however, the addition of 100fmol of Rad27
resulted in more robust cleavage of the substrate
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Figure 3. Rad27 stimulates the endonuclease activity of Mus81–Mms4. (A) Standard endonuclease assays for Mus81–Mms4 were carried out with
the enzyme levels as indicated. Two levels of Mus81–Mms4 (2.5 and 5fmol) were used in the presence of increasing amounts of Rad27 as indicated.
DNA substrate used was the 30F substrate (10fmol) and the mixtures were incubated for 30min at 30 C. Lanes 11 and 20 are the controls with
Rad27 alone carried out independently with the same amounts of enzymes. (B) The amount (fmol) of cleavage products formed in (A) was plotted
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7618 Nucleic Acids Research, 2010,Vol.38, No. 21(Figure 4A, lanes 11–16). This result demonstrates that
effective stimulation of Mus81–Mms4 activity by Rad27
requires higher concentrations (>5mM) of MgCl2. Thus,
we decided to use 10mM MgCl2 hereafter.
We also investigated whether Rad27 is able to stimulate
Mus81–Mms4 at physiological salt concentrations. For
this purpose, we tested varying concentrations (70, 100,
150, 200 and 250mM) of NaCl (Figure 4B) with a ﬁxed
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Nucleic Acids Research, 2010,Vol.38, No. 21 7619concentration (10mM) of MgCl2. Mus81–Mms4 activity
was hardly affected by addition of NaCl up to 150mM,
but signiﬁcantly inhibited by >200mM NaCl (Figure 4B,
compare lanes 2, 5, 8 and 11). We found that Mus81–
Mms4 activity was stimulated by Fen1 under all NaCl
concentrations tested. Besides, the extents of Mus81–
Mms4 stimulation by Rad27 were similar in the range of
70–150mM NaCl, conﬁrming that stimulation of Mus81–
Mms4 by Rad27 can occur at the physiological salt
concentration.
One potential mechanism by which Rad27 stimulates
Mus81–Mms4 activity is the nonspeciﬁc DNA binding
activity of Rad27 that helps dissociate Mus81–Mms4
from cleavage products, thereby rapidly recycling
Mus81–Mms4. To exclude this possibility, we examined
the effect of Rad27 on Mus81–Mms4 in the presence of
a stoichiometric amount with the 30F substrate DNA. If
stimulation were due to the nonspeciﬁc DNA binding
activity of Rad27, stimulation by recycling of Mus81–
Mms4 could be minimized when all the substrates were
occupied with Mus81–Mms4. For this reason, we
preincubated the 30F substrate and Mus81–Mms4
(equimolar), followed by addition of Mg
2+ (with or
without Rad27) to initiate reaction. Under this condition,
marked stimulation could not be expected due to the use
of a high level of Mus81–Mms4 with respect to the level of
substrate. As shown in Figure 4C, we carried out a
time-course experiment with reaction mixtures containing
equimolar amounts (10fmol each) of Mus81–Mms4 and
30F substrate in the absence (Figure 4C, lanes 2–9) and
presence (10fmol; Figure 4C, lanes 10–17) of Rad27. We
found that Rad27 was still able to stimulate Mus81–Mms4
activity (Figure 4C and D) more efﬁciently with shorter
incubation period of reaction. Therefore, this result
supports the notion that Rad27 stimulates Mus81–Mms4
via a speciﬁc protein–protein interaction and the stimula-
tion occurs during a single catalytic cycle (see also below).
When we examined the cleavage products in a
high-resolution gel, we found that the substrate speciﬁcity
as well as the cleavage products formed by both enzymes
remained identical, the same as that produced by each
enzyme alone. For example, Rad27 stimulated endonucle-
ase activity of Mus81–Mms4 with all DNA substrates
tested to a similar extent, indicating that the presence of
Rad27 did not alter substrate speciﬁcity of Mus81–Mms4
(data not shown). Analyses of cleavage products by a
high-resolution sequencing gels revealed that the
cleavage sites were not altered (data not shown).
Rad27 interacts directly with Mus81–Mms4
The marked mutual stimulation observed between Rad27
and Mus81–Mms4 prompted us to examine their physical
interaction. To this end, we prepared cell-free extracts
containing epitope-tagged Mus81-TAP and/or Rad27-
FLAG and one of the two tagged proteins
was immunoprecipitated with either PAP or anti-FLAG
monoclonal antibodies (Figure 5A). Immunoprecipitation
of Rad27-FLAG with anti-FLAG beads precipitated
Mus81 as well (Figure 5A, lane 5). We noted that expres-
sion of Mus81-TAP was inhibited by expression of
Rad27-FLAG (Figure 5A, compare lanes 2 and 3). This
might account for some background observed in control
in the absence of Rad27 (Figure 5A, lane 4). We also at-
tempted to conﬁrm direct interactions between Mus81–
Mms4 and Rad27 using puriﬁed proteins (Figure 5B).
Mms4 and Rad27, tagged with hexahistidine residues at
their N- and C-terminus, respectively, were immuno-
precipiated with anti-Rad27 polyclonal antibodies.
The resulting precipitates, probed with anti-His monoclo-
nal antibodies, revealed the presence of both Mms4 (and
thus Mus81) and Rad27 (Figure 5B, lane 5). Controls
indicated that the coimmuneprecipitation speciﬁcally
required the simultaneous presence of Rad27, Mus81–
Mms4 and anti-Rad27 antibodies (Figure 5B, lanes 3, 4
and 6). Coimmunoprecipitation in the presence of DNase
I did not affect the results above, indicating that the inter-
actions between the two proteins were not due to a DNA
contaminant (data not shown). Taken together, these
results indicate that Rad27 and Mus81–Mms4 interact
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Figure 5. Rad27 interacted physically with Mus81–Mms4. (A) The strains that expressed either Mus81–TAP or Rad27-FLAG or both were con-
structed as described in ‘Materials and Methods’ section. Crude extracts (5.5mg), derived from each strain as indicated at the top of ﬁgure, were
mixed with anti-FLAG antibody-conjugated agarose beads (40ml), and the mixtures were then incubated at 4 C for 2h in binding buffer (25mM
HEPES-NaOH/pH7.5, 150mM NaCl, 10% glycerol, 0.01% NP40). The agarose beads were collected by brief centrifugation, washed, and analyzed
by western blotting using either PAP or anti-FLAG (a-FLAG) monoclonal antibodies. WCE, whole cell extract (0.25mg); Ponceaus S indicates
loading controls stained with Ponceasu S. (B) Recombinant Mus81–His6Mms4 and Rad27-His6 (5pmol each) were mixed and incubated on ice for
1h in buffer containing 25mM HEPES-NaOH/pH7.5, 150mM NaCl, 10% glycerol and 0.01% NP40. After incubation, anti-Rad27 antibodies
(a-Rad27, 5ml) and protein-A agarose (5ml) were added to reaction mixtures, followed by an additional incubation for 1h at 4 C with rocking.
Western blot analysis was carried out with anti-His monoclonal antibodies (a-His).
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most likely depends on this property.
Enzymatic stimulation depends on speciﬁc
protein–protein interactions
The regions in Rad27 that contribute to its direct physical
binding to Mus81–Mms4 were examined. For this
purpose, a series of GST-fusion Rad27 fragments were
prepared as described in ‘Materials and Methods’
section (Figure 6A, top panel, Coomassie blue), and
examined for their ability to bind Mus81–Mms4 using
GST-pull-down assays. The presence of Mms4-His6 in
the precipitated complexes was examined by western
blot analysis with anti-His monoclonal antibodies
(Figure 6A, bottom panel, a-His Ab). All of the
GST-fusion Rad27 derivatives, except Rad27261–317 and
Rad27335–366 (Figure 6A, bottom panel, lanes 5 and 9,
respectively), interacted with Mus81–Mms4. GST or
GST-beads alone failed to do so (Figure 6A, bottom
panel, lanes 2 and 10), indicating that speciﬁc binding
occurred between Rad27 fragments and Mus81–Mms4.
We noted that two regions (between aa 318–334 and
367–382), ﬂanking the known PCNA binding motif (aa
340–347), bound Mus81–Mms4 (Figure 6C). Each
region alone was sufﬁcient to bind Mus81–Mms4, since
Rad27318–350 or Rad27351–382 interacted with Mus81–
Mms4 as efﬁciently as Rad27318–382 (Figure 6A, compare
lanes 6–8; see also Figure 6C). It appears that the amounts
of Mus81–Mms4 bound to GST-Rad27318–350,
GST-Rad27318–382 and GST-Rad27351–382 varied, but
this is most likely due to varying levels of GST-Rad27
fragments used for the GST pull-down assays (compares
lanes 6–8 in Figure 6A, bottom panel). Next, we tested
whether the GST-fusion Rad27 derivatives that bound
to Mus81–Mms4 were able to stimulate the enzymatic
activity of Mus81–Mms4 using the 30F substrate as
shown in Figure 6B (see also Figure 6C). We found that
Rad27 fragments containing only one of the two binding
regions (Rad271–366, lanes 8 and 9; Rad27318–350, lanes 12
and 13; Rad27351–382, lanes 14 and 15) or none (Rad27335–
366, lanes 16 and 17) failed to stimulate the activity of
Mus81–Mms4, whereas Rad27318–382 containing both
regions stimulated Mus81–Mms4 as efﬁciently as
Rad271–382 (full-length) (Figure 6B, compare lanes 6and
7 to 10 and 11). Each GST-fusion Rad27 derivative did
not cleave the 30F substrate, excluding the possibility that
the cleavage was due to contaminating activity derived
from E. coli (data not shown). Thus, simultaneous
presence of at least two binding motifs in Rad27 (that
support the binding of Mus81–Mms4) appears to be es-
sential for the stimulation of Mus81–Mms4 activity.
DISCUSSION
In this report, data are presented showing that the three
endonucleases, Rad27, Mus81–Mms4 and Dna2, inter-
acted genetically and functionally in vivo and in vitro.
Our experimental results suggest that MUS81–MMS4 is
involved in the processing of Okazaki fragments by virtue
of its genetic and functional interaction with DNA2 and
RAD27, both of which play critical roles in lagging strand
processing. In support of this notion: (i) Overexpression of
Mus81–Mms4 rescued growth defects associated with
dna2K1080E. Furthermore, we found that dna2-2 and
dna2-4, the two other dna2 mutant alleles isolated by
Formosa and Nittis (44) were also suppressed by
overexpression of Mus81–Mms4 (data not shown). (ii)
Mus81–Mms4 and Rad27 mutually stimulated the
structure-speciﬁc endonuclease activity intrinsic to each
protein. (iii) Finally, the functional interactions between
Rad27 and Mus81–Mms4 were shown to be mediated by
speciﬁc protein–protein interactions.
We believe that suppression of dna2 mutants by Mus81–
Mms4 occurred via stimulation of Rad27. A number of
previous results have shown that elevated levels of Rad27
can substitute for a functionally impaired Dna2. These
include: (i) Overexpression of Rad27 suppressed several
dna2 mutant alleles, including dna2-1 and dna2D405N
(31,45). (ii) We also have shown that the RAD27 gene
can suppress dna2K1080E mutant (data not shown). (iii)
Several suppressors of dna2 mutations were found to
stimulate the nuclease activity of Rad27. For example,
in vivo the nonessential yeast MGS1 gene could suppress
dna2 mutations, but in vitro the puriﬁed Mgs1 protein
stimulated Rad27, but not Dna2 endonuclease activity
(39). The observed suppression was absolutely dependent
on the presence of a functional copy of RAD27. Thus,
enhancement of Rad27 activity (or its abundance) could
lead to rapid removal of ﬂaps generated by pol d-catalyzed
displacement DNA synthesis. The net effect of this acti-
vation blocks formation of long ﬂaps. Normally, when
long ﬂaps are formed, they could bind RPA and are efﬁ-
ciently cleaved by Dna2, but resistant to cleavage by Fen1
(31). Thus, enhanced or elevated levels of Rad27 activity
could make cells less dependent on Dna2 activity, allowing
cells to grow with impaired Dna2 activity.
Although Rad27 and Mus81–Mms4 are involved in two
seemingly separate processes, their mutual stimulation
described in this study suggest a more direct
Figure 6. Continued
SDS-polyacrylamide gel and stained with Coomassie blue (top gel, Commassie blue). For GST-pull-down assays (bottom gel), 1pmol of
Mus81–Mms4 was mixed with 100pmol of GST (lane 2) or GST-fused Rad27 fragments (lanes 2–9) in binding buffer (25mM HEPES-NaOH/
pH7.5, 150mM NaCl, 10% glycerol, and 0.01% NP40). The reaction mixtures were incubated for 1h at 4 C with rocking. The complex formed was
collected by centrifugation and washed. The presence of Mus81–Mms4 in the precipitated materials was determined by western blotting using
anti-His monoclonal antibodies against His6-Mms4 (a-His Ab, bottom panel). Lane 1 contained 0.2pmol of Mus81–Mms4 as an input control. (B)
The reaction mixtures contained a ﬁxed amount (5fmol) of Mus81–Mms4, and the reactions were carried out with 10fmol of the 30F substrate and
two levels (50 or 100fmol) of GST-fused Rad27 fragments using standard reaction condition as described in ‘Materials and Methods’ section. The
cleavage products formed from the 30 F substrates were analyzed as described in Figure 2B. (C) A schematic summary of the results obtained in (A)
and (B). The numbers in each fragment indicate the positions of amino acids present in full-length Rad27.
7622 Nucleic Acids Research, 2010,Vol.38, No. 21interfunctional role between the two structure-speciﬁc
endonucleases. Based upon the genetic and biochemical
interactions between Rad27 and Mus81–Mms4, a model
can be proposed that may account for how they collabor-
ate in repairing unprocessed ﬂaps. All ﬂaps may not be
correctly processed for a variety of reasons. For example,
the two critical processing enzymes, Dna2 and Fen1, may
not be able to process efﬁciently ﬂaps that form a struc-
ture. Failure in processing such ﬂaps could result in for-
mation of double strand breaks in replicated lagging
strand, which are supposed to be resected by the MRX
complex to generate 30 ssDNA overhang. The 30 overhang
then would start homologous recombination by invading
replicated sister chromatid DNA, resulting in formation
of recombination intermediates that are toxic to cells
unless resolved. They can be normally removed by
Mus81–Mms4 or Sgs1–Top3. The choice between the
two pathways is governed by the availability of nicks in
the recombination intermediates. Thus, processing of re-
silient Okazaki fragments could be ultimately assisted by
Mus81–Mms4 when nicks are present in the recombin-
ation intermediates or by Sgs1–Top3 when all nicks are
sealed (46).
The joint role of Rad27 and Mus81–Mms4 could come
into effect via the interconversion between DNA struc-
tures speciﬁc for each endonuclease that arise from
reannealing of ﬂaps to the template DNA. It should be
noted that numerous structural intermediates, called
‘equilibrating ﬂaps’ (double-ﬂap DNA with both 50 and
30 ﬂaps of varying length) can result from the reannealing
of ﬂaps. These intermediates are not cleaved by either
Rad27 or Mus81–Mms4 until they convert into a struc-
tural form susceptible to cleavage by each enzyme. The 50
or 30 ﬂap can be converted into a 30 or 50 ﬂap, respectively,
in a manner similar to that seen in Holliday junction mi-
gration. If the equilibrating ﬂaps are trapped in a structure
suitable for the action of each endonuclease, they could be
processed more effectively and rapidly if the two enzymes
involved could stimulate each other’s activity. This could
constitute a feedforward and feedback stimulatory mech-
anism, increasing the rate of ﬂap removal. Although BLM
(47) and Mph1 (34) could directly stimulate Fen1, they are
able to migrate Holliday junctions. Therefore, it is con-
ceivable that the two helicases could contribute to
Okazaki fragment processing by facilitating conversion
of the equilibrating ﬂaps into a speciﬁc structure that
can be cleaved by one of the two enzymes. One example
is that Sgs1 drives the annealing process to completion by
virtue of its ability to displace the downstream strand. The
product formed by this reaction would contain a 50
ssDNA ﬂap that is a substrate for Fen1. Other helicase
may reverse this process to generate 30 ﬂap, structure that
can be processed by Mus81–Mms4. Recently, the human
BLM helicase was shown to stimulate nuclease activity of
the Mus81–Eme1 complex (47). In addition, Rad54 was
found to strongly stimulate Mus81–Mms4 in an
ATP-independent fashion in humans and yeasts (48).
This is interesting, considering that both BLM and
Rad54 are capable of mediating the migration of
branched DNA structures. Alternatively, a nuclease(s)
that can simultaneously process both 50 and 30 double
ﬂaps could reduce the length of both ﬂaps, and generate
more rapidly a DNA substrate that can be processed by
either Rad27 or Mus81–Mms4.
Although Rad27 and Mus81–Mms4 differ in their
structural substrate speciﬁcity, therefore, they can act
jointly to remove ﬂap structures more efﬁciently particu-
larly with aid of other protein factors that facilitate
inter-conversion of substrate DNA.
The mutual stimulatory effects of Rad27 and Mus81–
Mms4 also suggest that that Rad27 can play critical roles
in the resolution of toxic recombination intermediates and
the re-initiation of damaged RFs by activating the
Mus81–Mms4 complex (see ref. 46 for details). Mus81–
Mms4 is known to produce collapsed RFs, when RFs
encounter damaged DNA (16,22). Then, cells attempt to
repair collapsed RFs (produced by Mus81–Mms4 action)
by synthesis-dependent strand annealing initiated by
double-strand breaks. Therefore, the mutual stimulatory
effects of Rad27 and Mus81–Mms4 provide with cells
more effective means to restore damaged RFs. The collab-
oration between Rad27 and Mus81–Mms4/Sgs1-Top3
appears to be physiologically relevant since the
synthetic-lethal interaction was detected in cells harboring
mutations in MUS81 or SGS1 in combination with
rad27D (33,49,50). This view is also in keeping with the
ﬁnding that rad27D mutant was sensitive to HU, which
induces replication fork arrest (51).
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